Canada needs to ‘amp it up’ in wake of competitive U.S. and Chinese pharma policies, says Innovative Medicines Canada CEO
‘Where is R&D flourishing right now? It's not in the U.S. It's not in Europe. It's in China,’ says IMC’s Bettina Hamelin at Canada’s Drug Agency’s annual symposium.
As representatives for the Ontario government and the pan-Canadian Pharmaceutical Alliance say they are seeing results from their efforts to speed up access to medicines, Innovative Medicines Canada’s Bettina Hamelin says this country still has work to do if it wants ...
Get Innovation & Industry Newsletter
From investment to regulation, the policies, decisions and people working on industry and innovation. Tuesday.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
